BioNexus issues 410,000 shares as part of strategic AI partnership in Malaysia
BioNexus Gene Lab agreed to license CogniAI technology from Ruanyun Edai in exchange for shares and future investments expanding into Southeast Asia, marking a significant corporate expansion.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed